Publications
Berenson, F., Vasconcellos, E., Pakalnis, A., Mao, L., Biondi, D.M., Armstrong, R.B. (2010). Long-term, open-label safety study of oral almotriptan 12.5 mg for the acute treatment of migraine in adolescents.
Headache,
50(5), 795-807.
View in Pubmed